Table 2

Results of linear regression analyses for serum hepcidin concentration by site adjusted for age

VariableGambian childrenKenyan children
β (95% CI)*P*R2, %β (95% CI)*P*R2, %
Age, y 0.07 (0.03, 0.11) .001 1.2 −0.07 (–0.02, −0.12) .003 2.7 
BMI, kg/m2 −0.01 (–0.06, 0.03) .51 3.3 0.02 (–0.05, 0.09) .51 3.3 
Gender, female −0.03 (–0.12, 0.07) .59 1.2 −0.05 (–0.24, 0.14) .61 2.7 
Ethnicity, minority group −0.04 (–0.22, 0.13) .63 1.2 0.26 (–0.03, 0.55) .08 3.6 
Hb type, HbAS −0.04 (–0.19, 0.11) .62 1.1 −0.09 (–0.36, 0.17) .49 2.8 
G6PDd, A- type 0.11 (–0.12, 0.34) .33 1.2 −0.15 (–0.36, 0.06) .16 3.2 
Iron status       
 Log-ferritin, µg/L 0.98 (0.88, 1.08) <.0005 28.7 1.43 (1.26, 1.60) <.0005 43.8 
 Log-sTfR, mg/L −2.26 (–2.57, −1.96) <.0005 22.3 −3.26 (–3.60, −2.93) <.0005 37.3 
Hematologic status       
 Hb, g/dL 0.18 (0.15, 0.21) <.0005 14.3 0.37 (0.24, 0.50) <.0005 28.1 
 MCV, fL 0.03 (0.03, 0.04) <.0005 10.5 0.07 (0.05, 0.10) <.0005 36.4 
Inflammation       
 Log-ACT, g/L or log-CRP, mg/L 1.86 (1.49, 2.22) <.0005 8.4 0.65 (0.46, 0.84) <.0005 14.4 
Malaria       
 Season, end of malaria season −0.45 (–0.40, −0.51) <.0005 10.2 −0.46 (–0.35, −0.56) <.0005 9.1 
P. falciparum parasitemia −0.15 (–0.27, −0.03) .01 1.8 0.50 (0.28, 0.71) <.0005 5.9 
VariableGambian childrenKenyan children
β (95% CI)*P*R2, %β (95% CI)*P*R2, %
Age, y 0.07 (0.03, 0.11) .001 1.2 −0.07 (–0.02, −0.12) .003 2.7 
BMI, kg/m2 −0.01 (–0.06, 0.03) .51 3.3 0.02 (–0.05, 0.09) .51 3.3 
Gender, female −0.03 (–0.12, 0.07) .59 1.2 −0.05 (–0.24, 0.14) .61 2.7 
Ethnicity, minority group −0.04 (–0.22, 0.13) .63 1.2 0.26 (–0.03, 0.55) .08 3.6 
Hb type, HbAS −0.04 (–0.19, 0.11) .62 1.1 −0.09 (–0.36, 0.17) .49 2.8 
G6PDd, A- type 0.11 (–0.12, 0.34) .33 1.2 −0.15 (–0.36, 0.06) .16 3.2 
Iron status       
 Log-ferritin, µg/L 0.98 (0.88, 1.08) <.0005 28.7 1.43 (1.26, 1.60) <.0005 43.8 
 Log-sTfR, mg/L −2.26 (–2.57, −1.96) <.0005 22.3 −3.26 (–3.60, −2.93) <.0005 37.3 
Hematologic status       
 Hb, g/dL 0.18 (0.15, 0.21) <.0005 14.3 0.37 (0.24, 0.50) <.0005 28.1 
 MCV, fL 0.03 (0.03, 0.04) <.0005 10.5 0.07 (0.05, 0.10) <.0005 36.4 
Inflammation       
 Log-ACT, g/L or log-CRP, mg/L 1.86 (1.49, 2.22) <.0005 8.4 0.65 (0.46, 0.84) <.0005 14.4 
Malaria       
 Season, end of malaria season −0.45 (–0.40, −0.51) <.0005 10.2 −0.46 (–0.35, −0.56) <.0005 9.1 
P. falciparum parasitemia −0.15 (–0.27, −0.03) .01 1.8 0.50 (0.28, 0.71) <.0005 5.9 
*

The dependent variable hepcidin was log-transformed before inclusion in the linear regressions models, and all analyses (except for age) were adjusted for age. Ninety-five percent CIs and P values were adjusted to take account of potential within-subject clustering of events using the sandwich estimator.34 

These data were available for only 82 children at the end of the season and should be interpreted with caution. The dependent variable for these models was log-transformed hepcidin at the end of the malaria season (because Hb and MCV were not available at the start of the season).

Close Modal

or Create an Account

Close Modal
Close Modal